Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Eli Lilly and Company |
---|---|
Information provided by: | Eli Lilly and Company |
ClinicalTrials.gov Identifier: | NCT00058968 |
The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.
Condition | Intervention | Phase |
---|---|---|
Diabetic Neuropathy, Painful |
Drug: Duloxetine hydrochloride Drug: placebo |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy |
Estimated Enrollment: | 660 |
Study Start Date: | October 2002 |
Study Completion Date: | March 2005 |
The protocol will assess the efficacy and safety of duloxetine. It will also look at how duloxetine affects quality of life.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Florida | |
For additional information regarding investigative sites for this trial, contact 1-877-CTLilly (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. | |
Pembroke Pines, Florida, United States |
Study Director: | Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours EST) | Eli Lilly and Company |
Study ID Numbers: | 4097, F1J-MC-HMAV |
Study First Received: | April 15, 2003 |
Last Updated: | May 16, 2007 |
ClinicalTrials.gov Identifier: | NCT00058968 |
Health Authority: | United States: Food and Drug Administration |
neuropathy pain diabetes chronic pain persistent pain |
leg pain peripheral neuropathy foot pain painful neuropathy diabetic neuropathy |
Diabetic Neuropathies Diabetes Mellitus Endocrine System Diseases Pain Duloxetine Serotonin Signs and Symptoms |
Dopamine Neuromuscular Diseases Peripheral Nervous System Diseases Neurologic Manifestations Endocrinopathy Diabetes Complications |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Nervous System Diseases Physiological Effects of Drugs |
Psychotropic Drugs Serotonin Uptake Inhibitors Pharmacologic Actions Serotonin Agents Therapeutic Uses Dopamine Agents Central Nervous System Agents Antidepressive Agents |